COVID-19 and Public Health Update Copyrighted
October 16, 2023
City of Dubuque Action Items # 01.
City Council Meeting
ITEM TITLE: COVID-19 and Public Health Update
SUM MARY: Public Health Director Mary Rose Corrigan will present information on
current COVI D-19 information along with updates on other
communicable diseases and public health issues of interest for Fall,
22023.
SUGGESTED Receive and File; PresentationSuggested Disposition:
DISPOSITION:
ATTACHMENTS:
Description Type
MVM Memo City Manager Memo
Memo to MVM COVI D -19 and Public Health Update Staff Memo
COVI D-19 and Public Health Powerpoint Presentation Supporting Documentation
Dubuque
THE CITY QF �
All-Meriea Ciry
DLT B E ; . � . �
�� � �
MaSt� Z�C� aYd t�Q Mt55ZSSZ Z zoa�•zoiz•�ai3
YP pp za��*zai�
TO: The Honorable Mayor and City Council Members
FROM: Michael C. Van Milligen, City Manager
SUBJECT: COVID-19 and Public Health Update
DATE: October 11, 2023
Public Health Director Mary Rose Corrigan will present information on current COVID-
19 information along with updates on other communicable diseases and public health
issues of interest for Fall, 2023. The City Council requested an October update after
receiving the final COVID-19 update on April 17, 2023.
�
Mic ael C. Van Milligen
MCVM:sv
Attachment
cc: Crenna Brumwell, City Attorney
Cori Burbach, Assistant City Manager
Mary Rose Corrigan, Public Health Director
�UbUC�LIe Health Services Department
THE CITY OF � City xall AnneX
1300 Main Street
All-Americ�City Dubuque,ia s2oo i
UF E �.�Kn,���� ���,�
� � ��� Office(563)589-4181
Fax(563)589-4299
TTY(563)589-4193
health@cityofdubuque.org
2007*2012�20�.3 �,�,�,.cityofdubuque.org
Masterpiece on the Mississippi zoi�*zoi9
TO: Mike Van Milligen, City Manager
FROM: Mary Rose Corrigan, Public Health Director
SUBJECT: COVID-19 and Public Health Update
DATE: Oct 11, 2023
INTRODUCTION
This memorandum and presentation provide current COVID-19 information along with
updates on other communicable diseases and public health issues of interest for Fall,
2023. The City Council requested an October update after receiving the final COVID-19
update on April 17, 2023.
BACKGROUND
In previous COVID-19 reports, topics included Emergency Management Agency (EMA)
activities, hospital capacity planning, public information, vaccination, testing, treatment
and policy issues. Most of these topics are now part of other regular occurring public
health and health care meetings and planning. However, public health activities still
include vaccinations and vaccine education, monitoring COVID-19 sentinel and local
health care provider reports and working on the Improvement Plan from the COVID-19
pandemic after action report.
DISCUSSION AND PRESENTATION
• Current COVID-19 statistics and outlook
• Covid-19 Vaccines
• COVID-19 research.
• Seasonal respiratory diseases and monitoring
• Chronic Wasting Disease (CWD) in deer
• Sexually Transmitted Infections (STI's) or STDs
Council Action
No action required.
� �
�
�
�
UQ E CITY COVNCIL
�LI D- I 9 &
BLIC H EALTH ATE
a Rose Corri an, Publi �llth� tor �
rY J �
r
Oct I 6, 2023 �
� •
�
� —
COVIDISSTILLHERE
■ New sub-variants emerging
■ Immunity from past immunizations and/or infection have waned but are
still effective against some sub-variants
Isolation and Quarantine guidelines still in effect:
■ Quarantine (exposed) : https://www.cdc.qov/coronavirus/2019-
ncov/you r-health/if-you-were-exposed . htm I
■ Isolation (sick or tested positive) :
https ://www.cdc. .qov/coronavirus/2019-ncov/your-health/isolation . html
■ Adults 65/older
IOWA RESPIRATORY SURVEY
IOWA RESPIRATOR7 5UR1�EY-�OYJ�-14
Mumber nf��VID-I 9 Moletular Tests arxl Positire Pertertxage
Zaa�c
� i ort �
15,8�
F �
Y
� �
� ����� �
� t
� S� �
Weekly Cour�t�d Prnportion of lowa Emergenty Room YisitS for��YI�-14 �y 6
� s.o%
6.," �_ aK � ����L�L �� ���LJ�LJ���JJLJ � G,d�
5 fl � � ��" ��" ��"- ��"- C � � ��" C C 'm�' C C C C C C C C C �'�" C C ''"�' ''"�'
�,o� � - c '" c a c � c � °° � `° a �' a - c � c � c � �. � .� o
� a a r�+ ra _ .y ,-, a a �n .n .`a ,o �+ aa � e+ e�+
� A� L�} — — — — — — Week End��
� �
� ; Mumber of COYID-I 9 Antigen Tests and Positire Pertentage
� 344 #'�� �
� ZS:o
7 �
2476
V 244 � r� i000
i,a� � r �
I 44 11� � � � i 55� �
0,0� � 50d . I656 �
N N �J N N � N N �J �J N � N � �J ry N ry N N N N N N N ry N N N rv �J � �
a — � — aa � � — es � � S � 'a a aN � � — �s ", � � � a �: � a �: � m � �
— — — � a � � ,� '" ,, �-, C � � � � � r ;x .., � 3 3 3 '� ti n ti `� � as cs °- °' c o- e= 57G
COVIO Oefiniton,Waekly coun�of lawa resdenrs nsmng purucipaung lawa emergenq rooim and who lud a C4VID-19 discharge diagnasis.Propornon oi
a � � o00o Q ��
COVID-19�srcs uses che weekly wunc defined ahare as che n Wneraznr and che w�l of all lowans nvung parucipaung lawa emergenry rooms wich any vaLd discharge � � � �is" �i¢" � �=+ '�'�-+ � � � � � � � � � � � � f+ � � -`�'�+ r�+ �=+
dlagnasri. r+ — � N � � _ ry
3 .3 �3
3 3 = _ � � � *�' r� .-, � � � � � 3 '-'�3 rw R °� � °' a ay
1Neek End��
10.�
9
9.�
s.a �.�
�.a �.a
�
s.a
� �.�
� �.a �.s �.z
� �.a
� �.a z.� �.3
a 1.9
2.0
1 0.8 �.S
1.0 �.Z 0.3
0.�
. � � � �
� - 5 years fi - 11 years 1� - 17 years 18-34 years 35-49 years 5D-fi4 year� � 55 years
■ Ever ■ Current
�
Hospitalizations in children
35 3z
30
�
o � 26 �5
c 2� z3
N 27
�
�zO 19
v, 1b 17 17
0
� �5
0
�
a �o
u
L
�
� �
V
{5 months 5 months—{z years a—r� years �—s� years s�-17 years
■ COVID-1g ■ Influenza
� Infruenza Flosoita�rrat�ion 5urverllance Netwnrk
r/yLr Lr 11�I G 7
Bivalent COVID-19 vaccines no longer available
New monovalent vaccines approval by CDC all referred as updated 2023-24
vaccine
Spikevax (Moderna)
Comirnaty (Pfizer)
Novavax (for those who want another option)
Vaccines available commercially & private health insurance
� �
Free vaccine through Bridge Access Program for un�nsured �
and underinsured
, �
: r
Everyone 6 months and older should receive updated 2023-24 vaccine
vr � v vH � �
Children 6 months-4 years: 3 Novavax approved (2023-24
COVID-19 vaccine doses, formula Adjuvanted, monovalent
including at least 1 updated vaccine)
COVI D-19 dose. One dose If reviousl
( p Y
vacci nated with a ny COVI D -19
5 ears and older: 1 u dated vaccine)
Y p
Pfizer or Moderna COVI D-19 2 doses (if not previously
vacci ne. vacci nated with a ny COVI D-19
Covid-19 vaccine finder: vaccine)
�1 ����.iiWww.Vai:ClriC�.�Ov� 12 years and older
HTTPS: SPECIAL.USPS.COM TESTKITS
� �� �� ur fr�� � �- i� � r� �
::�
��1�IDi 'I � t���� th i � -� .
f� l I � n � �1lI �T����. ��r � �� � �
�� ,
� .
� �� f _ � � �
� . � ,�T-'� ,
Every lJ.S. household rr�ay place an arder to recei�re faur free � - �
CDlli�-19 rapid tests deltverec� direetf� �o your hame. , . ` - f . � ' � '
� �,.�-.- .` �
-r�. �-- x
��.F' � • + as�� �
; .�� � .�
. � 4_.:,,
'���ir�,�
�rder Free �l# Hame Tests '� a� ,
. �• .. ,�: , - .
� � � � r
�
Need help placin� an orderforyourat-I�omete�t�? � � ..
caii �-soo-���-o��� {��r �-�s�-��o-����). -, � �'�
���� �
The U.S. government wili cantinue to rr�ake COVID-1� tests _ - - .
- ���
availa�le to uni�sured individ�als and underserved �ornmunities
throug� existing outreaeh prograrr�s. Please c�ntact a �IRSI� �F — _- _��'
��
i�ealth center, Test to Treat s€te, ❑r ICATT locatian near �rou ta
■
RESPI RATORY SYNCYTIAL VI RUS RSV
■ RSV single dose
■ 2 vaccines available
■ Health care provider guidance
■ High risk- immunocompromised , chronic heart/lung condition , living in
long term care.
■ 60 years and older based on healthcare provider recommendation
■ Vaccination for 60 years and older
� • # ■ � � � � �
. � . -
. - ■ ' ■ ■ ■ - ■ - ; ■
� . -
� �4dults �� I��11 �r���ir�e Talk t� your da�t�r first
antl �v�r
�
� R�11 antib�d i�ren �II infants enterin� or k�orn during
y Babi�es to bab�r � R�11 s�as�n. �mall gro�p �f
alder babies fo� se�ond se�,son.
��
�
R�11 �raccine �ir�en �an get if ��u are 3�-3� v�eeks
� Babies durir��g pr�gr�ar���r �r��r�ar�t during �ep#�rr�ber Januar�r
. . �
II. � I
�
�
35.G95
Rh inrnirus!E nterori rus
2a.9°,6
34.G95
CQY��-1$
10.946
25.�95
�
4arainlluenxa virus
� Zo.o�s 4,3�
�
�
• � I S.G� ,4denorirus
2.2�G
I O.G95
In9uenxa
• 0.4`�6
S.G9d
RSY
6,4�
4.G9d
• � '� M r'�, r'�, �.TM.
� � .� a � � � "� � a � � � � � � � ��+ � � 5 � � 5 �
8 � � � � .� � � *�' :� '" .; � � � ; � � 3 {` � � s`6 �' a. o-
Week Endx�g
Tap S Pa[hogen Grnups hp Positive Perceret oo liespiratory Yines 5urve�-Mo-le��slar Only
�
•
•
�
•
�
•
• https://www.vaccines.qov/find-
.
vaccines/
•
������� ����� ���� versi6n:octzoz3 ���� ���� ����'��� Versiorcseptzo23
�Cu��ilcsson las ;�uicn es �Comofuncianan �c�and�deberia V'Vh�t �re V1lhv Is How 1Nell do IrVhen 5hould
the n tions? eli ible? the worl�? I et it?
apciones? elegib�e? de bien? ponermela? P 9 ]� 9
GRIPE INFLUEh1ZA
Una inyeccion � Octubrees lo _ Octaber is ide�l,
Reduce el ries o A shvtthat Redutes the risk
- A artir de I�s i����, � ���� 6 months and as vaccine
— dirigid�Contra R de ir al m�dico en � � — target5 4 strairls af gOirly ta the
4 ce as d�l �meses de �n 5,�� peotietti�rn baja a - of seasanal flu �Ider ���r����� protection wane6
.f. � ed�d lo I�rgo de I� ,�,� — over a season
I � +�irus tEmpor�d�
Para proteccion frenCe a Pratection ayainst
�Q�f�d-�� onfQrm$dadswnra:ahora �����-�� SeVefediSe�Se:Get �
Formul��ctualiaad� EI o#ano pasado, �ig� Updated v�cGine ��
de v�turl�dirigida a la vacuna da farmul�taryeting Lastyear,the f�ll
XB�- una suhnr�riante A partirde Ivs COVI�-19 ofreciti para pratecci�n frente a XB6-an 4rnicron ��onths and COVID-19 vaccine Protettion against
de Omicrorl 6 mesesde una afica�ia infacdbet:Lo mejoresantes � subaariant older provided 4d-6d96 in#etiion��estto get it
edad adicianal del de unaola.algadiHcil de additional riyht 6efore a wave,
� Opciones:Moderna y 4D9fa-649b frente determinar }w �P����y�,�,,���ef�y� effectiveness which can be
�r Pfixer tARhlm}� a enfermedad w� and pfi�er tmRNA}. �g�in5t se+�ere challenying totime
Nav�vax�Rroteirl�X severa �Se ha iitfectado dise�se
racientomenEe''Esper�3-4 Nouavax{protein} ReCently in#eCted?
i.,.,��g aualiable saan. Wait at least3-4
months �
VRS (EN ADULfi05 MAYDRES] Ahore. �a
� � , 2 opciones=GSI{y proteccion es R5Y (OLDER AdULTS�
� Pfizee.Su disena es 8245-$695 de duradera.no h�y
A partir de los 64 � 2 v tivns=G51�and
� � diferentE,salo� �cacia frente a necesidad de • • p
anos � 82-8695 effit�cy Now;na need to
nivel rnicrosco ico enfermedad severa buscar un mvmentiv �zer_Theyare �p years and
P �gainst se�rere juggle timiny as
oportuno � � slightlydifferentin older
� desiyn,but onlyat disease pro#ection is
a microscapic level durable
VFCS �EN EL EMBARA�D] 82�de eficecia er�
Personas En#re la5 seman�s
preverlir I� {�$�(����i��k���]
La vacuna de Rfizer, embarazadas{la 32-36de1
hospi#�IiZ�Cidn en l05 8296 efficaty in It's nat au�il�ble
se Ilama A6RYSV0 proteccibn pasa al embaraxb.sola de �r2gn�nt people
bebe y la protiege �rirri2ro5 3 me5e5 de �eptiembee a (then pratection will Rreventing yet but
vid�.694fi de efit�ti� Pfizer is BCtiuely ��s to bab far h���italf�ation in ❑�nte appro+�ed,
dueante las primera5 �����¢������� er12ro sEeking�RR���+�� R � first 3 months of get at Z4 to 36
6 meses de uida}_ ����� protettion in first 6 �ife.6996 efFcacy weeks of
manths of life�. �{ter 6 mbnths preynancy
ANTI�UERP�S IIRS
�teduce el ries�o de RSV MONOCLO�NAL ANTIBODY
Noes un�v�cuna Ino Totlos Ins bebes Ahora.
hbspitali�acion y
h�Ce que el cuerpo La pro#eccion This is not a vaccine
�S rne5es_ BebeS wisitas medicas en
} produzca an#icuerpas� dura de 4-6 {doesn't teach#Fte body p��inf�n#s�8 Redu�es risk of �'�1ill be�v�il�ble
de alta riesgo d� �proximadamente
sino una rnedicacion entre8-19 rneses meses # to make antibodies}bu# manths.High-risk haspitaliza#ion and �°�.
que�osaparta �� ��°�° rathera proactiwe infants 8-19 healthcare visits by
medic�tiOn(provides months �gpg� Prbkection I�sts
antibodies). 4-6 months
Por:F4�telyn]etelina.MPH PH�yCaitlin RiverS,MPH PHd.Traciurcion:Maria�oro,M�.MPH.M�9 informacionen Su
- Epldem�blaga Lacal - �Y���t�lyn�elelinv.l+'P-FHC and C�illin�r:ers,`ApH�-7.F•vr r.-ore inf•vrrnnLi•vn g�kn Ya..r L•vcnl=�:i�Lr.-iol•f�isk �
CHRONIC WASTING DISEASE IN DEER
��.�*E.�u c u •_
�° ?E" u n` ` 1 Dd,19S Total 1Nild Deer Sampled
a� i ��E s
:i_.,.,..,r, .�,� ���� - ����
F�d,��t��
L:,Crc•»� Farn.
.+;11-•art La� �.u�tin "
�•iaux Faii� •. � WiEd Population Positive
vc^ o�.,v+ e�� � «+�� �•,�-r ,;,�„�,� �,.,,.., WiEd Papulation Positive
'1fi:i�.eilicA .4{�ZY.Y
r ankion x°°"a' �- -
I•:1�•Ji�•:•n { 1
aser�ralion @fnar 4dw �mr Adolm Hs1xct .r.•.rin� ri�sx� .u�:r�sx .x L��
Fa�rlc Cl.h.
� ClefobA IIVJIeYkm Po[ah[!me � 1'.MAK FrnIM Hf1Y oRmer
5ampling 2062-2422
� nw�ia.., e:.,�.,�� �..z_. _.��x,�.
-- � a� sd eer..� ri°�" �� w.*
..P,e:kford C'�Cs'DSa�n���'esCo:l�cte�'2C•C2-2C'22
!•larf[•Ik �:`in.1��� �,,, .i�:��
.. R;.;r ����;. �.,�,�� ts�„taa t�e c� e� ec.r �k r�. a.sM � >3.20: 16.2�2
� 4�
c�ir ` >',83d 3.201
�•�r:� � �, � � � �.� w«.� � „�� I L L l ld���l�.
R�:n
� �� IAu:oIY[ � 5 .z��J �.S]¢
�:"�nl.�h�, �wxrmv�ve rm amr r�am-�� '+A�++-+ n+onon v:nx� k vrx rieenwpm I L L I I J•.�I': �.. .: �
� 7'9 1.203
" Lwia¢
Pas�tive Samples hy Year
eaia raarsmwy wm� U���i ra�.s., �.aa i.iar�c v�..r�: :rnman Hnh
:•Gr�ncll�l_jrn_I Lin•�oln o...._--
y �� Franrr. r+.� � kr��i�i n»r�. ���carrnc o. ��.��!i��,.� F?:•I'I1 I'lJ I
H�stin•�s � �
� ,.
r f,�] .
Ouinc�
'. II.LIFJ�:�I�. Sprin•:ifi•:Icl C",':�tur �� �
.r.`�[J!�s?�:•Il „ '-
� �;
- �� - _ � � � �
r�i,ni„u:,n ILL _ _ A _
.. „I•:�ns�s Citr � ��ti3 �4h^ y�ti`� 44.6 ,,,"� �L�tiz� �4� ��yu 4tiy, 4�jL
Esr. HER� ".� =—.. ,.,-- ..... - — . Pawercd6ytsri
V K1�/�11V V C C K 1`�1/�11V/�1La C 1`�1 C IV 1 r Kv�rwr►i
� Herd management . �
�
.�-��� ,�
. . � r �
D�scourage feed�ng deer & . � - F _ �
�e� »�,..y �
' - - �
feed stations � �` 5 '� �-:� '. �{ �� "
' � "`.�.:..��,� ��,t�ti
� ■ ■ � .. ,,,��;�
. . . �h`; ;r`�;;j;�;�`�;
CVD testing available — submit ���-� �
,, , :}��.
���� � �
samples � � �
��
� �)LTf�CJE 5EPTEMBER 1fi,2023-JANLIARYIO,2024
� Re p o rt s i c k d e e r to D N R �"�ragrQm tn conlro[excess deer within ihe ci�y limi!s
ar Qu6uque and�he surraunding oullying area.
� PROGRAM GOALS
. Limit dee�popula[ions wi[hin defined areas in tne city of�u6uque below
20 deer per square mile.
• Pmvide pu6lic educa[ion�egarding deer,their ha8itats,impact on na[ural
ha6ita[s,deterrenFsand population managemen[,cost of property damage
iP nothing is done,and potential health risks resulting fmm a Earge
deer popuEation tocitixens of�u6uque and m deer.
. Encourage eligi6le propeny owners to allowqualified dee�hunters
on Fhei�pmperty
. �iscou�age citizens from feeding deer.
. Monitor 1or and pre+ren[[he spread of Chronic Wasting➢isease{CWD}_
S EE�ETRIES
ON PRGE 3.
� � ' � � •
1.5 rr�illion
- CA5ES OF CHLAMYDlA ;
I � I / I � � 1 I 1 � _ �.,,� 3,s�i decrease sincc 2�1?
,{�-
G.'r
fi�.n.?�.: ':��• �
' . .--�,�— �Z��IJ�1
� • � � • � • � �i.-�4a� '� � P.: � CAS�S aF GaNaRRHEA
• � � � � � � 7P�::�inrre.�tiN tiinc?7G1'
� I,7���13
� � � • • / GASES OF SYPHILIS
�
r4°�5 incrcasc sircc 2011
i+
� � - . . - - 2,855 �
� � � � • . ' _ � CASES OF SYPHILIS ■
. . , � AMONGNEWBQRNS
2�355 i ncrea se s i nc e 2017
New STD cases 6y year. Syphilis All stages(Infectious and Late
Stage) AMYONE WHD HAS SE1{COULU �— p �AY&eRs xuAL MEN 15-2R
877 GETAH STd,BL1T SOME GRQLIPS �
Af2EM4REAFFECTEd —� Q PREGMANTPEDPLE
O RACIAiÐNIC MIh1DRIFY GROtJPS
�si
- � �I'_I 1., � . .. � � - - �. . .
0
soo v ��
g4 a�
D
aw
275 288 �..:.-.�.. .. . . ...� � ..�. ,..:� .. '. .:�. :;._. : ;;::.'-�'t'�
_,.�?;i:_:.. - .
226
zaz zaa ,�yJbd9'Ll��r�171i9 ,.Gi'.L'C�IL 1_r i i�,o]`.I i z r��o:�l:�-i�iz n:�,�.lia�ao3]i J p(WS iTiYYZ§�,
228
PREVENTTHESPREA� r ��� � �� I, . .. . , �.
138 OF STf75 WITH THR€E L �' e -� II`
70 � ..''S: .. .
2�11 2012 2G13 2019 2�715 201E 2�717 2018 2019 2020 2G2L 20': F�
2611 2012 2�13 2014 2U15 2016 2U17 2618 2019 2620 2021 2022 �� � �
/C ]38 225 Z}� 22� �i_ «� Z„= 3EU SCU ?�] 8�- � .
_. � :'_�.� _� '.
�' I
� . . .. -,_�� - .
�Ner:5T�cases 6v Year ' •���'*�`.�..� �� ` :,
a .- •��`'-
. :, , � ° ;;1;+':,i3°:.� i{;�• �,.��
_ 5'' '_ ' _ `\.:,x}�s .1+�'�� - . .. . .. -
' �:�t9-
� �
�
�
�
I N ?
.
I V I N
T HAN K-Y V
. •
.
.
.
� .
�
� _